Startups and university-backed projects worldwide can apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. I-CREATE supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to […]

Offering academics and SMEs a diverse range of Australian translational medical research capabilities. The Pipeline Accelerator aims to further reduce the cost of access to TIA and Phenomics Australia facilities and enable seamless access to the NDF to enable various therapeutic development projects,